Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 4/20 | 0.60 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.51 |
| ▸ | TLR4 | O00206 | 1/20 | 0.49 |
| ▸ | TLR2 | O60603 | 1/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CCR1 | P32246 | 2/20 | 0.48 |
| ▸ | CCR5 | P51681 | 2/20 | 0.48 |
| ▸ | CCR8 | P51685 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | METAP1 | P53582 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.48 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.48 |
| ▸ | KMO | O15229 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29883580 | 0.98 | GRM5 (0.62) | GRM5BCHEACHEDCTPP1TLR4 | |
| SCHEMBL3233604 | 0.98 | GRM5 (0.62) | GRM5BCHEACHEDCTPP1TLR4 | |
| SCHEMBL3767444 | 0.96 | GRM5 (0.57) | GRM5BCHEACHEDCTPP1TLR4 | |
| SCHEMBL29398603 | 0.94 | GRM5 (0.59) | GRM5BCHEACHEDCTPP1TLR4 | |
| SCHEMBL2480128 | 0.94 | GRM5 (0.59) | GRM5BCHEACHEDCTPP1TLR4 | |
| SCHEMBL9905077 | 0.84 | GRM5 (0.56) | GRM5BCHEACHEDCTPP1KDM4E | |
| SCHEMBL502867 | 0.83 | KDM4E (0.62) | GRM5TLR4TLR2CYP2A6KDM4E | |
| SCHEMBL29679578 | 0.83 | KDM4E (0.62) | GRM5TLR4TLR2CYP2A6KDM4E | |
| SCHEMBL3779014 | 0.82 | GRM5 (0.59) | GRM5DCTPP1TLR4TLR2CYP2A6 | |
| SCHEMBL3773686 | 0.82 | GRM5 (0.47) | GRM5DCTPP1CYP2A6METAP1CDC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598879-B1 | LUMINESCENCE DEVICE, DISPLAY APPARATUS AND METAL COORDINATION COMPOUND | CANON KK (JP) | 2015-12-02 | — | — | EP | disclosed |
| US-7534506-B2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7026062-B2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2006-04-11 | — | — | US | disclosed |
| EP-1191613-B1 | Luminescence device, display apparatus and metal coordination compound | CANON KK (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20060014047-A1 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2006-01-19 | — | — | US | disclosed |
| EP-1598879-A2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2005-11-23 | — | — | EP | disclosed |
| US-20050014025-A1 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2005-01-20 | — | — | US | disclosed |
| US-6815091-B2 | IRIDIUM, RHODIUM, OR PALLADIUM-PHENYLPYRIDINE COMPLEX WITH SPECIFIED SUBSTITUENT(S); HIGH-EFFICIENCY LUMINESCENCE, HIGH BRIGHTNESS FOR A LONG TIME WHILE MINIMIZING DETERIORATION IN LUMINESCENCE IN ENERGIZED STATE | CANON KABUSHIKI KAISHA (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20020064681-A1 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2002-05-30 | — | — | US | disclosed |
| EP-1191613-A2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2002-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014047-A1 | Luminescence device, display apparatus and metal coordination compound | SOD1, ICOSLG, CCRL2 | GRM5 2488/4885BCHE 1866/4885ACHE 605/4885 |
| US-20020064681-A1 | Luminescence device, display apparatus and metal coordination compound | CDYL, ZC3HAV1L, ICOSLG | GRM5 1723/4885BCHE 617/4885ACHE 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.